Miller D K, Ayala J M, Egger L A, Raju S M, Yamin T T, Ding G J, Gaffney E P, Howard A D, Palyha O C, Rolando A M
Department of Biochemical and Molecular Pathology, Merck Research Laboratories, Rahway, New Jersey 07065.
J Biol Chem. 1993 Aug 25;268(24):18062-9.
Interleukin-1 beta-converting enzyme (ICE) was purified from dialyzed cytoplasmic extracts of THP.1 human monocytic cells by a combination of DEAE-5PW and SP-5PW ion exchange and C4 reverse phase high performance liquid chromatography. Sequence information from tryptic and Asp.N peptides on the isolated 20-kDa (p20) and a 10-kDa (p10) proteins enabled the subsequent cloning of ICE (Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., Elliston, K. O., Ayala, J. M., Casano, F. J., Chin, J., Ding, G. J.-F., Egger, L. A., Gaffney, E. P., Limjuco, G., Palyha, O. C., Raju, S. M., Rolando, A. M., Salley, J. P., Yamin, T.-T., Lee, T. D., Shively, J. E., MacCross, M., Mumford, R. A., Schmidt, J. A., and Tocci, M. J. (1992) Nature 356, 768-774) and localized the active site Cys. Immunoblots with ICE specific antibodies and NH2-terminal sequencing indicated that ICE active column fractions contained in addition to p20 and p10 an alternatively processed form of the p20 protein (p22) containing an extra 16 amino acids NH2-terminal to the p20. Furthermore, immunoblot analysis of the ion exchange column effluent showed that p20 and p22 were found together in three separate fractions distinguished by differences in p10: an intact p10 with complete ICE activity, a COOH-terminally truncated form of p10 with decreased ICE activity, and an absence of p10 with no ICE activity. These results indicate that the p10 protein is essential for ICE activity and that the ICE holoenzyme contains an intact p10 subunit paired with a p20 or p22 catalytic subunit.
白细胞介素-1β转换酶(ICE)是通过DEAE-5PW和SP-5PW离子交换以及C4反相高效液相色谱相结合的方法,从THP.1人单核细胞的透析细胞质提取物中纯化得到的。对分离出的20 kDa(p20)和10 kDa(p10)蛋白质上的胰蛋白酶肽段和天冬氨酸内切肽段的序列信息进行分析,使得后续能够克隆ICE(索恩伯里,N. A.,布尔,H. G.,卡拉伊凯,J. R.,查普曼,K. T.,霍华德,A. D.,科斯图拉,M. J.,米勒,D. K.,莫利纳克斯,S. M.,魏德纳,J. R.,奥宁斯,J.,埃利斯顿,K. O.,阿亚拉,J. M.,卡萨诺,F. J.,钦,J.,丁,G. J.-F.,埃格,L. A.,加夫尼,E. P.,林朱科,G.,帕利哈,O. C.,拉朱,S. M.,罗兰多,A. M.,萨利,J. P.,亚明,T.-T.,李,T. D.,希夫利,J. E.,马克罗斯,M.,芒福德,R. A.,施密特,J. A.,和托奇,M. J.(1992年)《自然》356,768 - 774)并定位了活性位点半胱氨酸。用ICE特异性抗体进行的免疫印迹和氨基末端测序表明,ICE活性柱级分中除了p20和p10之外,还包含一种p20蛋白的可变加工形式(p22),该形式在p20的氨基末端额外含有16个氨基酸。此外,对离子交换柱流出物的免疫印迹分析表明,p20和p22在三个不同的级分中同时存在,这些级分通过p10的差异来区分:具有完整ICE活性的完整p10、ICE活性降低的p10的羧基末端截短形式以及没有ICE活性且不存在p10的形式。这些结果表明p10蛋白对ICE活性至关重要,并且ICE全酶包含一个与p20或p22催化亚基配对的完整p10亚基。